Zeria Pharmaceutical Co (TSE:4559) YoY EBITDA Growth : 110.92% (As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Zeria Pharmaceutical Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Zeria Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 110.92%.

Zeria Pharmaceutical Co's EBITDA per Share for the three months ended in Dec. 2023 was 円88.54.

Zeria Pharmaceutical Co YoY EBITDA Growth Historical Data

The historical data trend for Zeria Pharmaceutical Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zeria Pharmaceutical Co YoY EBITDA Growth Chart

Zeria Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EBITDA Growth

Get a 7-Day Free Trial

-6.03

8.13

35.26

22.92

27.62

Zeria Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															245.57	13.98	51.68	110.92	-195.18

Zeria Pharmaceutical Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Zeria Pharmaceutical Co's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(397.496	-	311.463)	/	\| 311.463 \|
=	27.62 %

Zeria Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(88.538	-	41.977)	/	\| 41.977 \|
=	110.92 %

Zeria Pharmaceutical Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Zeria Pharmaceutical Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Zeria Pharmaceutical Co (TSE:4559) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zeria Pharmaceutical Co Ltd (TSE:4559) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

10-11, Nihonbashi Kobuna-cho, Tokyo, JPN, 103-8351

Website

http://www.zeria.co.jp

Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment.

Zeria Pharmaceutical Co (TSE:4559) Headlines

No Headlines